CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Taysha Gene Therapies - CapyFin

Taysha Gene Therapies

TSHA · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reported earnings 3 months ago

Previous year: $1.11M

Previous year: -$0.09

Previous year: $15.1M

Previous year: $7.34M

Total operating expenses

Previous year: $22.4M

Cash and Equivalents

Previous year: $173M

Previous year: $200M

Loading...

Key Statistics

Market Cap

$1.24B

P/E Ratio

-12.75

Sector

N/A

Industry

N/A

52-Week High

$5.88

52-Week Low

$1.11

R&D expenses

$20.1M

G&A expenses

$8.6M

Total operating expenses

$28.7M

Net loss per share

-$0.09

W.A. shares outstanding

297.99M

Taysha Gene Therapies

Unlock previous datapoints

Taysha Gene Therapies

Unlock previous datapoints

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...